Related Experiment Video
Updated: Feb 15, 2026
06:50
A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
Published on: September 16, 2022
3.6K
Candida Tropicalis Cholangitis in a Patient Without Underlying Malignancy
Arjun Saradna1, Shyam Shankar2, Benhoor Shamian2
1Internal Medicine, Maimonides Medical Center.
Cureus
|January 30, 2018
Summary
Candida tropicalis rarely causes acute cholangitis, typically in immunocompromised patients. This case highlights a rare instance of mixed-organism cholangitis, including C. tropicalis, in an individual without typical risk factors.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Gastroenterology
Background:
- Acute cholangitis is an infection of the biliary tract.
- Candida tropicalis is an uncommon pathogen in acute cholangitis.
- Hematological malignancies are a known risk factor for C. tropicalis-associated cholangitis.
Observation:
- A case of acute cholangitis was observed.
- The infection involved multiple microorganisms: Candida tropicalis, Candida albicans, and Enterococcus durans.
- The patient had no previously identified risk factors for this type of infection.
Findings:
- This report details a rare case of acute cholangitis caused by a polymicrobial infection.
- Candida tropicalis was identified as a causative agent in a patient without typical predisposing conditions.
- The presence of mixed organisms, including two Candida species and Enterococcus durans, is noteworthy.
Implications:
- This case expands the understanding of C. tropicalis as a pathogen in biliary tract infections.
- It suggests that acute cholangitis can occur due to mixed organisms even in the absence of known risk factors.
- Further research may be needed to elucidate the pathogenesis and optimal management of such polymicrobial cholangitis cases.
Keywords:
candidacandida albicanscandida tropicalischolangitiscritical illnessgall bladdericuintensive care unitmalignancyseptic shockMore Related Videos
Related Concept Videos
01:13Patient-centered Care
3.1K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.1K
01:15Drug Dosing: Geriatric Patients
280
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
280
01:21Drug Dosing: Obese Patients
269
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
242
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
242
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
279
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
279
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
334
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334